Abstract:Objectives: Upper limb lymphedema secondary to breast cancer treatment is the leading cause of lymphedema in France. Despite improved surgical practices and de-escalation of radiotherapy, the risk of lymphedema after breast cancer still affects 5-20% of patients, with this variation depending on the measurement method used and the population studied. Lymphedema has a negative impact on quality of life and body image, and their possible occurrence remains a major concern for all women treated for breast cancer. The Sénologie Commission of the Collège national des gynécologues et obstétriciens français (CNGOF) asked four specialists in breast surgery or lymphology to prepare a summary on the prevention, medical and surgical management of lymphedema after breast cancer treatment, and to discuss the medical and surgical innovations currently being evaluated. Methods: This synthesis was based on national and international guidelines on the management of upper limb lymphedema after breast surgery and a recent review of the literature focusing on the years 2020-2023. Results: From a preventive point of view, the restrictive instructions imposed for a long time (reduction in physical activity or the carrying of loads, air travel, exposure to the sun or cold, etc.) have altered patients' quality of life and should no longer be recommended. A good understanding of risk factors enables us to target preventive actions. Examples include obesity, a sedentary lifestyle, axillary clearance, radiotherapy of the axillary fossa in addition to axillary clearance, total mastectomy, taxanes or anti-HER-2 therapies in the adjuvant phase. Resumption of physical activity, minimally invasive axillary surgery, de-escalation of radiotherapy and breast-conserving surgical procedures have all demonstrated their preventive value. When lymphedema does occur, early management, through complete decongestive physiotherapy, can help reduce its volume and prevent its long-term worsening. Conclusion: Surgical (lymph node transplants, lympho-vascular anastomoses) and medical (prolymphangiogenic growth factors) approaches to lymphedema treatment are numerous, but require long-term evaluation of their efficacy and adverse effects.

Modern surgical treatments for lymphedema

Review of Current Surgical Treatments for Lymphedema

Surgical options for lymphedema after gynecological cancer treatment: current trends and advances

Surgical Approaches to the Prevention and Management of Breast Cancer–Related Lymphedema

Updates on Excisional Procedures for Lymphedema

Review of treatment strategies after lymphadenectomy: From molecular therapeutics to immediate microsurgical lymphatic reconstruction

Advances in lymphedema: An under-recognized disease with a hopeful future for patients

Combined Approach to Surgical Treatment of Lymphedema.

Breast Cancer-Related Lymphedema: A Review of Management and Innovative Surgical Techniques

Lymphoedema following surgery for breast cancer

The Top 100 Cited Articles in the Microsurgical Treatment for Lymphedema

Techniques and Outcomes in Microsurgical Treatment of Posttraumatic Lymphedema: A Systematic Review

Comprehensive review of vascularized lymph node transfers for lymphedema: Outcomes and complications

Surgical treatment of secondary lymphedema of the upper limb by stepped microsurgical lymphaticovenous anastomoses

Lymphatic Tissue Bioengineering for the Treatment of Postsurgical Lymphedema

Lymphoedema surgery in Australia: a narrative review

Review of the Evidence of Lymphedema Treatment Effect

Lymphedema: New Concepts in Diagnosis and Treatment

Lymphological Liposculpture for Secondary Lymphedema after Breast Cancer and Gynecological Tumors: Long-Term Results after 15 Years

[Update of indications and techniques for the management of lymphedema after breast cancer surgery]

Conservative treatment of lymphedema: the state of the art